大环内酯类抗生素治疗慢性气道炎性疾病的非抗感染研究进展(3)
[14]中华医学会呼吸病学分会哮喘学组.难治性哮喘诊断与处理专家共识[J].中华结核和呼吸杂志,2010,33(8):572-577.
[15] Gotfriedm H,Rose J,Chad R M,et al.Effects of six- week clarithromycin therapy in corticosteroid-dependent asthma:a randomizeddouble-blind,placebo-controlled pilot study[J].Curr Ther Res,2011,65(2):1-12.
[16] Simpson J L,Powell H,Boyle M J,et al.Clarithromycin targets neutrophilic airway inflammation in refractory asthma[J].Am J Respir Crit Care Med,2015,177(1):48-55.
[17] Mikailov A,Kane I,Aronoff S C,et al.Utility of adjunctive macrolide therapy in treatment of children with asthma:a systematic review and meta-analysis[J].J AsthmaAllergy,2013,6(1):3-9.
[18]何杰,楊济桥,童翔,等.大环内酯类抗生素对 COPD 患者急性加重频率影响的系统评价[J].中国呼吸与危重监护杂志,2013,12(1):12-17.
[19] Tam A,Sin D D.Pathobiologic mechanisms of chronic obstructive pulmonary disease[J].Med Clin North Am,2012,96(1):681-698.
[20] Diego A D,Milar A J,Mar Tinez-Mor AGóN E,et al.Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchitctasis[J].Respirology,2013,18(7):1056-1062.
[21] Li Y N,Liu L,Qiao H M,et al.Post-infectious bronchiolitisobliterans in children:a review of 42 cases[J].BMC Pediatr,2014,14(1):238.
[22]吴小英,罗征秀,符州,等.儿童闭塞性细支气管炎28例临床分析[J].中国当代儿科杂志,2013,15(10):845-849.
[23]李喆宇,崔玉彬,张静霞,等.大环内酯类抗生素的研究新进展[J].国外医药抗生素分册,2013,34(1):6-14.
[24] No authors listed.In brief:FDA azithromycin warning[J].Med Lett Drugs Ther,2013,55(1413):28.
[25]刘积峰,钟小宁,何志义,等.小剂量罗红霉素对支气管扩张患者症稳定期治疗的影响[J].中华结核和呼吸杂志,2012,35(11):824-827.
[26] Kanoh S,Rubin B K.Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications[J].Clin Microbiol Rev,2010,23(3):622-626.
[27] Kadota J H,Mukae H,Ishii T,at al.Long-term efficacy andsafety of clarithromycin treatment in patients with diffuse panbronchiolitis[J].Respir Med,2013,97(7):844-850., 百拇医药(卢文德)
[15] Gotfriedm H,Rose J,Chad R M,et al.Effects of six- week clarithromycin therapy in corticosteroid-dependent asthma:a randomizeddouble-blind,placebo-controlled pilot study[J].Curr Ther Res,2011,65(2):1-12.
[16] Simpson J L,Powell H,Boyle M J,et al.Clarithromycin targets neutrophilic airway inflammation in refractory asthma[J].Am J Respir Crit Care Med,2015,177(1):48-55.
[17] Mikailov A,Kane I,Aronoff S C,et al.Utility of adjunctive macrolide therapy in treatment of children with asthma:a systematic review and meta-analysis[J].J AsthmaAllergy,2013,6(1):3-9.
[18]何杰,楊济桥,童翔,等.大环内酯类抗生素对 COPD 患者急性加重频率影响的系统评价[J].中国呼吸与危重监护杂志,2013,12(1):12-17.
[19] Tam A,Sin D D.Pathobiologic mechanisms of chronic obstructive pulmonary disease[J].Med Clin North Am,2012,96(1):681-698.
[20] Diego A D,Milar A J,Mar Tinez-Mor AGóN E,et al.Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchitctasis[J].Respirology,2013,18(7):1056-1062.
[21] Li Y N,Liu L,Qiao H M,et al.Post-infectious bronchiolitisobliterans in children:a review of 42 cases[J].BMC Pediatr,2014,14(1):238.
[22]吴小英,罗征秀,符州,等.儿童闭塞性细支气管炎28例临床分析[J].中国当代儿科杂志,2013,15(10):845-849.
[23]李喆宇,崔玉彬,张静霞,等.大环内酯类抗生素的研究新进展[J].国外医药抗生素分册,2013,34(1):6-14.
[24] No authors listed.In brief:FDA azithromycin warning[J].Med Lett Drugs Ther,2013,55(1413):28.
[25]刘积峰,钟小宁,何志义,等.小剂量罗红霉素对支气管扩张患者症稳定期治疗的影响[J].中华结核和呼吸杂志,2012,35(11):824-827.
[26] Kanoh S,Rubin B K.Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications[J].Clin Microbiol Rev,2010,23(3):622-626.
[27] Kadota J H,Mukae H,Ishii T,at al.Long-term efficacy andsafety of clarithromycin treatment in patients with diffuse panbronchiolitis[J].Respir Med,2013,97(7):844-850., 百拇医药(卢文德)